Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AramarkARMK · Entity 3359 | Director | August 29, 2019 | September 04, 2019 |
| CHESAPEAKE UTILITIES CORPCPK · Entity 4195 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aramark
Report date August 29, 2019 · Filed September 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,603.4045 |
Reported balance
After 2019-08-29 transaction · row 1
1 source rowRow 1 · 2019-08-29 · Grant · Acquired 61 · Balance 22,603.4045 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
CHESAPEAKE UTILITIES CORP
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,932 |
Reported balance
After 2026-05-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 1,112 · Balance 4,932 F1: Shares issued for director compensation under the Company's Stock Incentive and Compensation Plan. F2: Includes 4,590 deferred stock units of which 1,112 are from the reported award and 38 were acquired by the reporting person since the last filing through reinvestment of dividends pursuant to a dividend reinvestment plan. Deferred stock units will be settled on a one-for-one basis in common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares issued for director compensation under the Company's Stock Incentive and Compensation Plan.
F2: Includes 4,590 deferred stock units of which 1,112 are from the reported award and 38 were acquired by the reporting person since the last filing through reinvestment of dividends pursuant to a dividend reinvestment plan. Deferred stock units will be settled on a one-for-one basis in common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date February 01, 2021 · Filed April 02, 2021
Section 16 reporting ended · disclosed 2021-04-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,103 |
Reported balance
After 2021-02-01 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2021-02-01 · Grant · Acquired 77,457 · Balance 100,103 F1: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 64,983 |
Reported balance
After 2021-04-01 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2021-04-01 · Tax withholding · Disposed 35,120 · Balance 64,983 F2: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 66,417 |
Reported balance
After 2021-04-01 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2021-04-01 · Tax withholding · Disposed 1,190 · Balance 66,417 F3: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 23,942 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 23,942 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 3,523 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 3,523 |
| ESOP Common StockSEC Table I · non-derivative | IndirectDirect | 655 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 655 |
| Stock UnitSEC Table I · non-derivative | Direct | 32,145.773 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 32,145.773 |
| Phantom Stock CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 469.0358 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 469.0358 F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.26 · Expires 2022-04-01 | Direct | 34,241 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 34,241 F6: Option became exercisable in four equal annual installments, commencing 4/1/2016. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 39,433 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 39,433 F7: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 55,098 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 55,098 F8: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 64,222 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 64,222 F9: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 141,405 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 141,405 F10: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 98,558 |
Reported balance
Holding disclosure · report date 2021-02-01 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 98,558 F11: The number of shares subject to the option were calculated using a 30-day average price. F12: Options became exercisable in four equal annual installments, commencing 4/1/2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
F2: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
F3: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.
F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F8: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F9: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F10: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F11: The number of shares subject to the option were calculated using a 30-day average price.
F12: Options became exercisable in four equal annual installments, commencing 4/1/2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2013 Filed Nov 25, 2013 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 15,299 | $36.23 | $554,282.77 |
DisclosureSEC source: 0001127602-13-032779 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 27,538 | $54.53 Strike: $54.53 | $1,501,647.14 |
DisclosureSEC source: 0001127602-13-013280 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,538 Underlying: Common Stock · 27,538 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 6,419 | $54.53 | $350,028.07 |
DisclosureSEC source: 0001127602-13-013280 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,128.0004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,768 | $52.66 | $251,082.88 |
DisclosureSEC source: 0001127602-13-007328 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,476 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 17, 2013 Filed Feb 19, 2013 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 293 | $51.12 | $14,978.16 |
DisclosureSEC source: 0001127602-13-006736 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,708 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 12,057 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · derivative · entry 12 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,173 Underlying: Common Stock · 12,057 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 13,838 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · derivative · entry 11 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,838 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 30,598 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · derivative · entry 10 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,299 Underlying: Common Stock · 30,598 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 12,057 | $48.48 | $584,465.49 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · nonDerivative · entry 6 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,147 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 13,838 | $48.41 | $669,933.56 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · nonDerivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,204 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 30,598 | $48.40 | $1,481,007.46 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · nonDerivative · entry 4 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,042 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 12,057 | $34.96 | $421,512.72 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · nonDerivative · entry 3 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 13,838 | $41.17 | $569,710.46 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2012 Filed Oct 3, 2012 19:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 30,598 | $36.23 | $1,108,565.54 |
DisclosureSEC source: 0001127602-12-028179 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 11,341 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · derivative · entry 7 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,341 shares Expires 2014-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/2/2008 Read SEC document |
| July 03, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,354 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · derivative · entry 6 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,354 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| July 03, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 11,341 | $48.00 | $544,368.00 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · nonDerivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,147 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| July 03, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,354 | $48.03 | $257,144.59 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · nonDerivative · entry 4 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,488 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $48.02 and $48.03 per share. Read SEC document |
| July 03, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 11,341 | $34.42 | $390,357.22 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · nonDerivative · entry 3 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,354 | $28.10 | $150,447.40 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2012 Filed Jul 5, 2012 20:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,938 | $46.89 | $184,652.82 |
DisclosureSEC source: 0001127602-12-021802 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,147 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 31,056 | $45.07 Strike: $45.07 | $1,399,693.92 |
DisclosureSEC source: 0001127602-12-013303 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,056 Underlying: Common Stock · 31,056 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,578 | $45.07 | $116,190.46 |
DisclosureSEC source: 0001127602-12-013303 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,085 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 7,766 | $45.07 | $350,013.62 |
DisclosureSEC source: 0001127602-12-013303 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,968.0004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| February 22, 2012 Filed Feb 23, 2012 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 10,706 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-12-007639 · form4.xml · derivative · entry 9 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,354 Underlying: Common Stock · 10,706 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| February 22, 2012 Filed Feb 23, 2012 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 11,987 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-12-007639 · form4.xml · derivative · entry 8 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,987 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/3/2007. Read SEC document |
| February 22, 2012 Filed Feb 23, 2012 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 10,706 | $43.67 | $467,531.02 |
DisclosureSEC source: 0001127602-12-007639 · form4.xml · nonDerivative · entry 4 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,590 F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $43.66 and $43.69 per share. Read SEC document |
| February 22, 2012 Filed Feb 23, 2012 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 10,706 | $28.10 | $300,838.60 |
DisclosureSEC source: 0001127602-12-007639 · form4.xml · nonDerivative · entry 3 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2012 Filed Feb 23, 2012 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 11,987 | $43.67 | $523,472.29 |
DisclosureSEC source: 0001127602-12-007639 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,590 F1 · price: Represents weighted average sale price for this trading day. Multiple sales ere executed, with sales prices ranging between $43.66 and $43.69 per share. Read SEC document |
| February 22, 2012 Filed Feb 23, 2012 20:54 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 11,987 | $30.04 | $360,029.55 |
DisclosureSEC source: 0001127602-12-007639 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2012 Filed Feb 21, 2012 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 214 | $44.27 | $9,473.78 |
DisclosureSEC source: 0001127602-12-007072 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,590 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 277 | $44.27 | $12,262.79 |
DisclosureSEC source: 0001127602-12-007072 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,804 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,571 | $43.08 | $110,758.68 |
DisclosureSEC source: 0001127602-12-004963 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,571 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 48,230 | $34.96 Strike: $34.96 | $1,686,120.80 |
DisclosureSEC source: 0001127602-11-012432 · form4.xml · derivative · entry 4 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,230 Underlying: Common Stock · 48,230 shares Expires 2018-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 12,872 | $34.96 | $450,005.12 |
DisclosureSEC source: 0001127602-11-012432 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,847.0004 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments, 50% on 4/1/2014 and 50% on 4/1/2016. Read SEC document |
| March 01, 2011 Filed Mar 3, 2011 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,207 | $33.04 | $105,959.28 |
DisclosureSEC source: 0001127602-11-008740 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 18, 2011 Filed Feb 22, 2011 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-006761 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,966 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2011 Filed Feb 22, 2011 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 293 | $32.76 | $9,598.68 |
DisclosureSEC source: 0001127602-11-006761 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,179 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 12, 2011 Filed Feb 16, 2011 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 356 | $33.03 | $11,758.68 |
DisclosureSEC source: 0001127602-11-005822 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,619 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| November 09, 2010 Filed Nov 10, 2010 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 12,381 | $0.00 Strike: $20.21 | $0.00 |
DisclosureSEC source: 0001127602-10-027662 · form4.xml · derivative · entry 4 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,381 shares Expires 2014-09-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Remaining option became exercisable in three equal installments on 9/8/2007. Read SEC document |
| November 09, 2010 Filed Nov 10, 2010 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 12,381 | $31.04 | $384,306.24 |
DisclosureSEC source: 0001127602-10-027662 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Read SEC document |
| November 09, 2010 Filed Nov 10, 2010 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 12,381 | $20.21 | $250,220.01 |
DisclosureSEC source: 0001127602-10-027662 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 45,897 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010576 · form4.xml · derivative · entry 3 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,897 Underlying: Common Stock · 45,897 shares Expires 2017-04-01 F2 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010576 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,544.7226 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015. Read SEC document |
| February 18, 2010 Filed Feb 19, 2010 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005616 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005616 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,059.7226 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on three equal installments, commencing 2/17/2011. Read SEC document |
| February 12, 2010 Filed Feb 17, 2010 21:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005085 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.